Xeptiva Therapeutics

  • Home
  • Company
    • About us
    • Team
  • Innovation
    • Technology
    • Pipeline
    • Target diseases
  • Clinical Trial
    • FAQs
  • News
    • See news
    • Press
  • Blog
  • Contact
  • Home
  • Company
    • About us
    • Team
  • Innovation
    • Technology
    • Pipeline
    • Target diseases
  • Clinical Trial
    • FAQs
  • News
    • See news
    • Press
  • Blog
  • Contact

FELINE ATOPIC SKIN SYNDROME

Feline atopic skin syndrome (FASS) is an inflammatory and pruritic skin syndrome of cats manifested by a spectrum of reaction patterns and represents one of the most prevalent skin diseases among cats (20%).

The age of onset is variable but generally is 5 years. The signs may be seasonal or nonseasonal. Purebred cats may have a higher risk than domestic shorthaired cats.

As in dogs, pruritic cats may have several clinical presentations (eg, miliary dermatitis, symmetric alopecia, eosinophilic granuloma complex, head and neck pruritus) that are consistent with a diagnosis of FASS but that must be differentiated from other diseases with similar clinical signs.
Picture
Management for feline atopy is life-long and usually involves various treatments and lifestyle changes or adjustments for the patient as well as pet owners. Depending on severity of the disease, patient and owner compliance as well as overall patient health, an individualized treatment plan is usually designed. 

At Xeptiva, we have designed and produced a novel therapy to target the inflammation that underlies FASS in cats. Proof-of-concept clinical studies have shown that our technology (Xep04) is a safe, well tolerated, and effective strategy to tackle this hard to manage condition.

COMPANY

About Us
Team

INNOVATION

Technology
Pipeline
Target diseases

clinical trial

NEWS

See News
Press releases

cONTACT

BLOG

© COPYRIGHT 2025.  ALL RIGHTS RESERVED.